Category Archives: Pharma Industry Image

The Growing Profile and Influence of ICER

The year began with a prediction from Senator Mitt Romney to pharmaceutical executives that “change is coming”. There have been high profile hearings on the topic in the Congress and legislation that moved in both the Senate and the House … Continue reading

Posted in Pharma Industry Image, Pricing and Value | Tagged , , | Comments Off on The Growing Profile and Influence of ICER

In the Pharma Pricing Debate, We Are Talking About More Than Apples and Oranges

This week the Senate Finance Committee held the second in what will be four hearings on the price of pharmaceutical drugs – Drug Pricing in America: A Prescription for Change. The first hearing, on January 29, listened to a panel … Continue reading

Posted in Pharma Industry Image, Pricing and Value | Comments Off on In the Pharma Pricing Debate, We Are Talking About More Than Apples and Oranges

Perspective on Pharma Support for Patient Advocacy Organizations

Last week Kaiser Health News (KHN) released a database called “Pre$cription for Power” that tracked pharmaceutical company donations made to patient advocacy groups, with an extensive accompanying article.  The database is an important collection of information and serves to enhance transparency … Continue reading

Posted in Pharma Industry Image, Politics | 1 Comment

Release of CMS Medicare Payment Data a Sunshine Dress Rehearsal

There were two major healthcare stories last week.  One involved the announcement that Health and Human Services Secretary Kathleen Sebelius would be leaving and the nomination by President Obama of Office of Management and Budget Director Sylvia Mathews Burwell to … Continue reading

Posted in Industry Image, Pharma Industry Image | Comments Off on Release of CMS Medicare Payment Data a Sunshine Dress Rehearsal

Let the Sunshine Part 3 – Taking it on the Road: Transparency Outside the U.S.

The past two days have been focused on The Physician Payment Sunshine provisions of the Patient Protection Affordable Care Act in the U.S. which will require the reporting of financial relationships between medical product manufacturers and medical providers by 2013. … Continue reading

Posted in Pharma Industry Image, Podcast | Comments Off on Let the Sunshine Part 3 – Taking it on the Road: Transparency Outside the U.S.